Physician profile
Arjun Saini
NPI 1740741024
$1,825.14
in general payments reported to CMS, 2019-2025
16 companies · $536 in 2025
The $536 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $322 · 2023: $114 · 2024: $853 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.73 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $591.51 | 2022-2025 | |
| Arcutis Biotherapeutics, INC. | $183.00 | 2024-2025 | Zoryve |
| Genzyme Corporation | $157.87 | 2024-2025 | |
| Dermavant Sciences, INC. | $155.18 | 2024 | Vtama |
| Janssen Biotech, INC. | $137.84 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $122.22 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $109.30 | 2024-2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $94.48 | 2022-2025 | Nemluvio |
| Incyte Corporation | $61.83 | 2024 | Opzelura |
| Lilly USA, LLC | $56.49 | 2024 | Taltz, Olumiant |
| Mayne Pharma Commercial LLC | $39.87 | 2024 | |
| Botanix Sb INC | $26.39 | 2025 | Sofdra |
| Ucb, INC. | $25.88 | 2025 | Bimzelx |
| Amgen INC. | $25.67 | 2024 | Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.94 | 2024 | Siliq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Strata Skin Sciences, INC. | $18.67 | 2025 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Saini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.